Verition Fund Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-104,334
| Closed | -$200K | – | 2869 |
|
|
2025
Q1 | $200K | Buy |
+104,334
| New | +$200K | ﹤0.01% | 2388 |
|
|
2023
Q4 | – | Sell |
-55,870
| Closed | -$63.7K | – | 1852 |
|
|
2023
Q3 | $63.7K | Buy |
+55,870
| New | +$63.7K | ﹤0.01% | 1807 |
|
|
2022
Q3 | – | Sell |
-10,673
| Closed | -$4K | – | 2417 |
|
|
2022
Q2 | $4K | Buy |
+10,673
| New | +$4K | ﹤0.01% | 2176 |
|
|
2018
Q2 | – | Sell |
-13,739
| Closed | -$131K | – | 982 |
|
|
2018
Q1 | $131K | Buy |
+13,739
| New | +$131K | 0.01% | 992 |
|